Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

119 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Multicenter Harmonization Study of Pan-Trk Immunohistochemistry for the Detection of NTRK3 Fusions.
Adam J, Stang NL, Uguen A, Badoual C, Chenard MP, Lantuéjoul S, Maran-Gonzalez A, Robin YM, Rochaix P, Sabourin JC, Soubeyran I, Sturm N, Svrcek M, Vincent-Salomon A, Radosevic-Robin N, Penault-Llorca F. Adam J, et al. Among authors: soubeyran i. Mod Pathol. 2023 Aug;36(8):100192. doi: 10.1016/j.modpat.2023.100192. Epub 2023 Apr 20. Mod Pathol. 2023. PMID: 37084942
Thyroid pathologic findings in patients with Cowden disease.
Harach HR, Soubeyran I, Brown A, Bonneau D, Longy M. Harach HR, et al. Among authors: soubeyran i. Ann Diagn Pathol. 1999 Dec;3(6):331-40. doi: 10.1016/s1092-9134(99)80011-2. Ann Diagn Pathol. 1999. PMID: 10594284
[Large core of nonpalpable breast lesions].
MacGrogan G, Henriques C, De Mascarel I, Soubeyran I, Molimard J, Barreau B, Tunon De Lara C, Bussieres E, Dilhuydy MH. MacGrogan G, et al. Among authors: soubeyran i. Arch Anat Cytol Pathol. 1998;46(4):241-6. Arch Anat Cytol Pathol. 1998. PMID: 9754385 French.
Prostate cancer and PARP inhibitors: progress and challenges.
Teyssonneau D, Margot H, Cabart M, Anonnay M, Sargos P, Vuong NS, Soubeyran I, Sevenet N, Roubaud G. Teyssonneau D, et al. Among authors: soubeyran i. J Hematol Oncol. 2021 Mar 29;14(1):51. doi: 10.1186/s13045-021-01061-x. J Hematol Oncol. 2021. PMID: 33781305 Free PMC article. Review.
IGHV gene features and MYD88 L265P mutation separate the three marginal zone lymphoma entities and Waldenström macroglobulinemia/lymphoplasmacytic lymphomas.
Gachard N, Parrens M, Soubeyran I, Petit B, Marfak A, Rizzo D, Devesa M, Delage-Corre M, Coste V, Laforêt MP, de Mascarel A, Merlio JP, Bouabdhalla K, Milpied N, Soubeyran P, Schmitt A, Bordessoule D, Cogné M, Feuillard J. Gachard N, et al. Among authors: soubeyran p, soubeyran i. Leukemia. 2013 Jan;27(1):183-9. doi: 10.1038/leu.2012.257. Epub 2012 Sep 4. Leukemia. 2013. PMID: 22944768
[Oesogastric cancer - new therapeutic targets].
Palmieri LJ, Soubeyran I, Pernot S. Palmieri LJ, et al. Among authors: soubeyran i. Bull Cancer. 2023 May;110(5):560-569. doi: 10.1016/j.bulcan.2022.08.005. Epub 2022 Nov 10. Bull Cancer. 2023. PMID: 36371284 Review. French.
Targeting ERBB2 mutations in solid tumors: biological and clinical implications.
Cousin S, Khalifa E, Crombe A, Laizet Y, Lucchesi C, Toulmonde M, Le Moulec S, Auzanneau C, Soubeyran I, Italiano A. Cousin S, et al. Among authors: soubeyran i. J Hematol Oncol. 2018 Jun 25;11(1):86. doi: 10.1186/s13045-018-0630-4. J Hematol Oncol. 2018. PMID: 29941010 Free PMC article.
119 results